FENC
Fennec Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.62
−1.48%Forward multiples
Based on analyst estimates
- P/E forward
- 18.70x
- P/E 2026E
- 37.55x
- P/E 2027E
- 11.30x
- P/E 2028E
- 6.49x
- P/S forward
- 4.32x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.77x
- Price / sales
- 6.29x
- Price / cash flow
- -182.56x
Enterprise value
- Enterprise value
- $331.2M
- EV / sales
- 5.59x
- EV / EBITDA
- -139.38x
- EV / EBIT
- -284.75x
- Market cap
- $372.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026